<ul><li>Mankind Pharma has completed the acquisition of Bharat Serums and Vaccines for Rs 13,768 crore.</li><li>This acquisition positions Mankind Pharma as a market leader in the women's health and fertility drug market in India.</li><li>BSV is known for its strong R&D capabilities and a robust portfolio of branded products in women's health, fertility, critical care, and immunoglobulins.</li><li>The acquisition aims to ensure wider access to specialized treatments and unlock new possibilities for both companies.</li></ul>

Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,768 Cr

Discover more